The policy was developed to aid in preventing recurrence and secondary cancers when possible, support the appropriate disease management through surveillance and follow up care, abating preventable pain, disability and psychological distress for those living with cancers and survivors, and facilitating patients’ access to resources related to their disease. Additionally, it gives other providers a guideline of what to look for and monitor after a patient is no longer being followed by their oncologist. For example, secondary cancers or ongoing tests. (CDC